The fight against COVID19
23.75k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Performance
| Watchlist | Change today | 1-month return | 1-year return | Total return |
|---|---|---|---|---|
| The fight against COVID19 | +1.13% | - | - | - |
| ^GSPC | -0.27% | -4.64% | +16.57% | +4510.81% |
14 symbols
| Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 155.75 | -1.13 | -0.72% | 4:00 pm GMT-4 | 7.68M | 22.75M | 375.05B |
| ABBV | AbbVie Inc. | 149.06 | -3.19 | -2.10% | 4:01 pm GMT-4 | 5.58M | 4.68M | 263.10B |
| PFE | Pfizer Inc. | 33.17 | +1.08 | +3.37% | 4:02 pm GMT-4 | 42.42M | 24.34M | 187.28B |
| SNY | Sanofi | 53.64 | +0.63 | +1.19% | 4:00 pm GMT-4 | 3.95M | 1.27M | 134.49B |
| GILD | Gilead Sciences, Inc. | 74.94 | -0.48 | -0.64% | 4:00 pm GMT-4 | 4.18M | 5.44M | 93.38B |
| REGN | Regeneron Pharmaceuticals, Inc. | 822.96 | -11.61 | -1.39% | 4:00 pm GMT-4 | 409.77k | 523.43k | 89.34B |
| GSK | GSK plc | 36.25 | -0.09 | -0.25% | 4:00 pm GMT-4 | 4.21M | 3.38M | 74.23B |
| TAK | Takeda Pharmaceutical Company Limited | 15.47 | -0.12 | -0.77% | 4:00 pm GMT-4 | 1.34M | 2.13M | 48.30B |
| MRNA | Moderna, Inc. | 103.29 | +3.02 | +3.01% | 4:00 pm GMT-4 | 4.20M | 3.86M | 39.31B |
| BNTX | BioNTech SE | 108.64 | +6.61 | +6.48% | 4:00 pm GMT-4 | 1.19M | 685.71k | 26.05B |
| VIR | Vir Biotechnology, Inc. | 9.37 | +0.16 | +1.74% | 4:00 pm GMT-4 | 1.19M | 1.57M | 1.26B |
| NVAX | Novavax, Inc. | 7.24 | +0.08 | +1.12% | 4:00 pm GMT-4 | 8.14M | 9.14M | 730.54M |
| INO | Inovio Pharmaceuticals, Inc. | 0.389 | +0.01 | +2.45% | 4:00 pm GMT-4 | 970.00k | 3.14M | 104.28M |
Motley Fool3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way.
Simply Wall St.Is Regeneron Pharmaceuticals (NASDAQ:REGN) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Motley FoolCould Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
When you think of the products populating your medicine cabinet -- like Band-Aid bandages or Tylenol -- you might not think of Kenvue (NYSE: KVUE). After all, these items have Johnson & Johnson written all over them -- literally. Speaking of rewarding shareholders, Kenvue is off to a good start, initiating a dividend during its very first months of operation as an independent company.
